Narcolepsy Market
Increasing prevalence of narcolepsy, growing the obese population, increasing demands for effective treatment, rising research and development are estimated to be some of the significant drivers for the global narcolepsy market.
Narcolepsy Market is expected to register a CAGR of 9.7 % with USD 7.1 billion by 2032
Various factors are adding to the global narcolepsy market share. These factors, as per the new MRFR report, include favorable reimbursement policies, increase in healthcare expenditure, increase in research and development activities for finding a cure for narcolepsy, extensive efforts undertaken by non-government and government organizations to spread awareness about narcolepsy, and growing demand for advanced therapies for sleeping disorders. Additional factors adding market growth include an increase in stress levels, rising cases of narcolepsy for an unhealthy lifestyle, and increasing awareness about sleep disorders.
On the contrary, low per capita healthcare expenditure in middle low-income countries and lack of awareness are factors that may impede the global narcolepsy market growth over the forecast period.
Major Key Players:
Some of the Narcolepsy Market Players are Jazz Pharmaceuticals plc (Republic of Ireland), BIOPROJET (Paris), Arena Pharmaceuticals, Inc. (U.S.), Graymark Healthcare, Inc. (U.S.), Mylan N.V. (U.S., Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Shire (Republic of Ireland), Shionogi Inc. (U.S.), Ligand Pharmaceuticals, Inc. (U.S.), and others.
Segment Analysis
The MRFR report provides an inclusive segmental analysis of the global narcolepsy market based on end user, treatment, type, and diagnosis.
By type, the global narcolepsy market is segmented into type 2 narcolepsy, type 1 narcolepsy, and others.
By diagnosis, the global narcolepsy market is segmented into multiple sleep latency test, polysomnogram, and others.
By treatment, the global narcolepsy market is segmented into sodium oxybate, antidepressants, stimulants, and others. The stimulants segment is again segmented into armodafinil, modafinil, and others. The antidepressants segment is again segmented into noradrenergic reuptake inhibitors, selective serotonin, tricyclics, and others. The tricyclics segment is again segmented into clomipramine, desipramine, imipramine, and others. The selective serotonin noradrenergic segment is again segmented into fluoxetine, venlafaxine, and others.
By end users, the global narcolepsy market is segmented into retail pharmacies, clinics, hospitals, and others.
Regional Analysis
Based on the region, the global narcolepsy market covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period for a huge patient population, high healthcare expenditure, the presence of key industry players, and a well-developed healthcare sector. Canada and the US are the chief contributors in the region.
The global narcolepsy market in Europe is predicted to have the second-largest share over the forecast period for the presence of developed economies such as Germany, Italy, and France, increasing cases of obesity, huge patient population, and availability of funds for research and development.
The global narcolepsy market in the APAC region is predicted to grow at a quick pace over the forecast period for favorable government policies, developing healthcare sector, and the presence of developing economies such as China India.
The global narcolepsy market in the MEA is predicted to have the smallest share in the market over the forecast period for stringent government policies in the African region and weak economies. The market in the Middle East will have a favorable growth for the huge healthcare expenditure due to the presence of several developed economies such as Qatar, Kuwait, and Saudi Arabia.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
